Loading...
•
Dec 31, 2022
Colgate Q4 2022 Earnings Report
Colgate-Palmolive Demonstrated Strong Growth Momentum in Q4 2022
Key Takeaways
Colgate-Palmolive reported a net sales increase of 5.0% and organic sales growth of 8.5% in Q4 2022. EPS declined 94% to $0.01, driven by goodwill and intangible assets impairment charges related to the Filorga skin health business. On a Base Business basis, EPS declined 3% to $0.77.
Net sales increased by 5.0% in the fourth quarter.
Organic sales grew by 8.5% with growth in every division and in all four categories.
GAAP EPS decreased 94% to $0.01 due to impairment charges.
Base Business EPS decreased 3% to $0.77.
Colgate
Colgate
Colgate Revenue by Segment
Revenue by Segment
OPHC North America Revenue
CapyFin.comOPHC Latin America Revenue
CapyFin.comOPHC Europe Revenue
CapyFin.comOPHC Asia Pacific Revenue
CapyFin.comOPHC Africa/Eurasia Revenue
CapyFin.comPet Nutrition Revenue
CapyFin.com Forward Guidance
The Company expects net sales growth to be 2% to 5%, including the benefit from acquisitions and a low-single-digit negative impact from foreign exchange. Organic sales growth is expected to be towards the high end of its long-term targeted range of 3% to 5%.
Positive Outlook
- Net sales growth of 2% to 5% expected.
- Benefit from acquisitions of pet food businesses.
- Organic sales growth expected towards the high end of 3% to 5% range.
- Gross profit margin expansion expected on a GAAP basis.
- Double-digit earnings-per-share growth expected on a GAAP basis.
Challenges Ahead
- Low-single-digit negative impact from foreign exchange.
- Increased advertising investment.
- Low to mid-single-digit earnings-per-share growth expected on a non-GAAP basis.
- Uncertain macroeconomic conditions worldwide.
- Challenges in duty-free, travel retail, and pharmacy channels due to government restrictions and reduced consumer mobility.
Revenue & Expenses
Visualization of income flow from segment revenue to net income